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Abstract There is a growing interest in using hydrogels
for biomedical applications, because of more favourable
characteristics. Some of these hydrogels can be activated
by using particular stimuli, for example electrical fields.
These stimuli can change the hydrogel shape in a prede-
fined way. It could make them capable of adaptation to
patient-specific anatomy even post-implantation. This is
the first paper aiming to describe in vivo studies of
an electro-responsive, Pluronic F127 based hydrogel, for
intravascular applications. Pluronic methacrylic acid
hydrogel (PF127/MANa) was in vitro tested for its hae-
molytic and cytotoxic effects. Minimal invasive implanta-
tion in the carotid artery of sheep was used to evaluate its
medium-term biological effects, through biochemical,
macroscopic, radiographic, and microscopic evaluation.
Indirect and direct testing of the material gave no indica-
tion of the haemolytic effects of the material. Determina-
tion of fibroblast viability after 24 h of incubation in an
extract of the hydrogel showed no cytotoxic effects.
Occlusion was obtained within 1 h following in vivo
implantation. Evaluation at time of autopsy showed a
persistent occlusion with no systemic effects, no signs of
embolization and mild effects on the arterial wall. An
important proof-of-concept was obtained showing bio-
compatibility and effectiveness of a pluronic based electro-
responsive hydrogel for obtaining an arterial occlusion
with limited biological impact. So the selected pluronic-
methacrylic acid based hydrogel can be used as an
endovascular occlusion device. More importantly it is the
first step in further development of electro-active hydrogels
for a broad range of intra-vascular applications (e.g. system
to prevent endoleakage in aortic aneurysm treatment, intra-
vascular drug delivery).
1 Introduction
In recent years there have been significant advances in the
development of hydrogels for biomedical applications.
These water-swollen macromolecules have many advan-
tages. First of all they can swell/deswell several times their
original volume. They are stable in aqueous and biofluids
at physiological temperature, pH, and ionic strength [1].
Due to their high water contents and soft consistency
hydrogels resemble natural living tissue more than any
other class of synthetic biomaterials and several of these
gels are found to be biocompatible [2–4]. Moreover, their
physical and chemical properties can vary with composi-
tion [5, 6], and they can conform to various shapes [7].
Other novel functionalities of these polymers could also
possibly be utilised. For example the shape-memory effect,
these polymers change their shape in a predefined way
when exposed to a suitable stimulus. This stimulus can be a
chemical reaction, a temperature change, electrical fields,
solvents and light [8, 9]. The most commonly studied
biomedical application for this type of hydrogel is drug
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delivery, where an applied stimulus causes the hydrogel to
deswell which releases a specified volume of drug [10]. A
potential new application could be creating an intravascular
occlusion by using the hydrogel’s ability to expand or
shrink when stimulated. In fact several medical procedures
require the occlusion of a blood vessel: treatment of vas-
cular bleeding, aneurysm sac occlusion, etc. Previously
non-stimuli responsive hydrogels have been used to coat a
coil [11] or to be injected in an aneurysm sac [12]. This
paper evaluates the biocompatibility and vascular occlu-
sion capability of a pluronic-methacrylic acid based hy-
drogel that exhibits strong electro-mechanical actuation
[13].
2 Materials and methods
2.1 Hydrogel
The synthesis of the hydrogel (PF127/MANa) used in this
paper has been described in detail [13]. Pluronic-bis-
methacrylate (PF127-BMA) powder 15 wt% was mixed
with methacrylic acid sodium salt (MANa) 10 wt% in
nitrogen gassed de-ionised water and cooled for 8 h. Free
radical polymerization was obtained by adding an initia-
tor, 1 M ammonium persulfate (APS) (Sigma Aldrich
A3678). As an accelerator 1 M tetramethylethylenedi-
amine (TEMED) (Sigma Aldrich T9281) solution was
used. The mixture was then placed in a PVC mould and
refrigerated for 1 h. Finally, the created hydrogel was
cured at 37 C for 3 h. After polymerization the hydrogel
was removed from the mould and transferred to a phos-
phate buffered saline solution (PBS). This solution was
refreshed three times a day for three consecutive days.
Thereafter the hydrogel was air dried for three consecu-
tive days.
2.2 Biocompatibility
2.2.1 Haemolytic tests
2.2.1.1 Haemoglobin determination To determine the
free haemoglobin concentration the Drabkins reagent
method was used in accordance with the international
standard (ASTM F756-08) [14]. Drabkins reagent converts
haemoglobin to the cyanoderivative [15]. The colour
intensity measured at 540 nm is proportional to the total
haemoglobin concentration. Fresh human blood, anticoag-
ulated with acid citrate dextrose, from three donors, was
mixed and used. The free plasma haemoglobin concentra-
tion was lower than 2 mg/ml (0.53 mg/ml). The blood was
diluted with an appropriate amount of calcium- and mag-
nesium-free PBS to adjust the total haemoglobin content to
10 ± 1 mg/ml. For the direct test and the extract test a
haemolytic index was calculated using the following
equation:
%Hemolysis ¼ ðHb testsample Hb negativecontrolÞðHb positive controm Hb negative controlÞ
 100
2.2.1.2 Extract testing A dried cylindrical hydrogel
sample (Ø3.5 mm 9 14.3 mm) was placed in a tube with
20 ml PBS for 24 h at 37 C. Then 0.1 ml of diluted blood
added to 0.7 ml of extract was added to the tube, and this
mixture was placed in a test tube rack for 3 h at 37 C. The
tube was gently inverted three times every 30 min to
maintain good contact with the blood and extract. At the
end of the incubation time the sample was centrifuged for
15 min at 750 G. The supernatant was carefully removed
and 0.250 ml was added to 0.250 ml Drabkins solution.
This mixture was allowed to stand for 15 min at 37 C.
After this 0.1 ml of this solution was placed in a 96-well
plate and the absorbance was recorded with a spectropho-
tometer at a wavelength of 540 nm. The haemoglobin
concentration of the supernatant was calculated using a
standard curve. Six test samples, 6 positive controls (H20),
and 6 negative controls (extract of high density poly-
ethylene (HDPE)) were evaluated.
2.2.1.3 Direct testing Cylindrical hydrogel samples, with
dimensions Ø3.0 mm 9 7.6 mm, were inserted in tubes
immersed in a mixture of 0.7 ml PBS and 0.1 ml of diluted
blood for 3 h at 37 C. Each tube was gently inverted three
times every 30 min to maintain good contact between
blood and material. At the end of the incubation time the
samples were centrifuged for 15 min at 750 G. The
remaining steps were identical to the steps described for the
‘‘Extract testing’’.
2.2.2 Cytotoxicity
2.2.2.1 Culture conditions Mouse L929 fibroblasts were
obtained from European Collection of Cell Cultures
(ECACC No. 88102702) and routinely cultured in a min-
imal essential medium supplemented with 10 % foetal calf
serum, 1 % MEAA, 1 % penicillin G, 1 % streptomycin
sulphate, 10 ll/ml L-glutamine. Cultures were maintained
in an atmosphere of 5 % CO2 in air at 37 C, and the
medium was changed every 48 h.
2.2.2.2 Extract testing The in vitro cytotoxicity was
evaluated by means of the dilution test method, ISO
10993-5 [16]. This test exposes fibroblasts grown to
near-confluence to fluid-extracts from the material under
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investigation. Cells seeded in a concentration of 1.105/ml
were cultured for 24 h in a 96-well microplate. There-
after the medium was exchanged with the extract of the
test samples. These extracts were obtained by placing a
cylindrical gel sample (Ø7.6 mm 9 25 mm), swollen in
PBS, into 20 ml of culture medium for 24 h at 37 C.
Dilutions (1/1, 1/2, 1/4, 1/10, 1/100, 1/1000) were fab-
ricated with sterilized culture medium. As a negative
control, a culture medium having been in contact with
HDPE was used (50 9 50 9 1 mm sample in 17.3 ml
medium). As a positive control phenol (6.4 g/L) was
used. For each condition six samples were tested. After
24 h of incubation, cell viability was assessed with the
quantitative colorimetric MTT assay (Vybrant MTT Cell
Proliferation Assay Kit, Molecular Probes) [17, 18]. The
cell viability percentage was reported as function of
control.
2.2.3 In vivo evaluation
2.2.3.1 Implantation The Ethical Committee for animal
experiments at the KU Leuven approved the experimen-
tation (number P144-2010). Hydrogel cylinders
(Ø3 mm 9 15 mm) were implanted in the carotid artery
of three sheep in a minimal invasive way. The sheep were
sedated with intramuscular injection of ketamine (15 mg/
kg). Anaesthesia was induced with isoflurane 5 %, the
animal was intubated and an oral-gastric tube was placed.
Anaesthesia was maintained with isoflurane (2–4 %). An
intravenous line and arterial line in both ears were
inserted. Heart rate, blood pressure, end-tidal CO2, and
blood O2 saturation were constantly monitored. The left
side of the neck was shaved. The carotid artery was
isolated proximal and distal from the intended implant
site of the hydrogel. Flow measurements were performed
using a Doppler-flow probe. Heparine (100 U/kg) was
administered before sheath placement. Proximal a 4 Fr
sheath was placed for pressure measurement and
angiography. Distally an 11 Fr sheath was placed for
hydrogel delivery and pressure measurements. The
delivery system, as shown in Fig. 1, consisted of a 9 Fr
conventional sheath, straight 0.014-inch guidewire, and
an occlusion balloon. After reaching the target destina-
tion, the occlusion balloon was inflated. Angiography was
used every ten minutes to assess the occlusion status.
After obtaining occlusion all attributes used for the
implantation procedure were removed and a final
angiography, pressure-, and flow measurement were per-
formed. The sheaths were retracted and the puncture side
of the carotid artery was closed with stiches. The inci-
sions were closed in layers.
2.2.3.2 Clinical and macroscopic evaluation The health
status of the animals was checked on a daily basis. Blood
samples were taken before implantation, and 2 and 4 weeks
after implantation. The blood samples were analysed for
blood cell count, ion content, signs of haemolysis (free
haemoglobin, LDH), and blood urea nitrogen. Four weeks
after implantation the sheep were sedated with intramus-
cular injection of ketamine and anaesthesia was performed
using isoflurane (2–4 %). Computer tomography was
conducted and an experienced radiologist performed an
evaluation on the carotid arteries, and brains looking for
signs of embolization. Next the entire carotid arteries were
isolated. Proximal and distal from the hydrogel an arterial
catheter was placed for pressure measurement. Flow was
measured using a Doppler flow device. After this, heparin
was administered and the animal was euthanized using a
high-dose pentobarbital and potassium. The left carotid
artery and surrounding tissue were subsequently explanted.
A full autopsy was performed evaluating all organs to
detect any signs of gel embolization or toxic effects.
2.2.3.3 Microscopic evaluation The explanted hydrogel
and vessel were evaluated macroscopically, separated and
processed for histological analysis by haematoxylin and
eosin staining. An experienced pathologist performed an
evaluation of the architecture and inflammatory response of
the explanted carotid artery. Samples that had been in direct
contact with the hydrogel were compared with samples
from unaffected carotid artery sections (taken 5 cm more
proximal). An evaluation of the architecture and reaction of
the intima; inflammation, fiber architecture and thickness of
the media; and inflammatory reaction within the adventitia
was carried out. A scoring system from 0 to 3 was used to
describe the inflammatory response and fiber disruption.
‘‘0’’ indicating no inflammation or intact fiber architecture,
and ‘‘3’’ a pronounced inflammation or disruption of fibres.
The observer was blinded for the sample group.
Fig. 1 Delivery device with guidewire (a), hydrogel (b), occlusion
balloon (c), and delivery sheath (d)
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3 Results
3.1 Biocompatibility
3.1.1 Haemolytic tests
Extract and direct testing of the hydrogel gave no indi-
cation that the material has haemolytic properties. The
amount of free haemoglobin, after contact with an extract
of the hydrogel or with the hydrogel surface was com-
parable with the negative control. This was represented
in the percentage of haemolysis: 0.06, and 1.86 %,
respectively.
3.1.2 Cell toxicity tests
Figure 2 shows fibroblast viability after 24 h of incubation
in an extract of the hydrogel. The viability of the cells
after contact with the extract is 81 per cent. The positive
control, phenol, is toxic until a dilution of 1 over 10 is
reached.
4 In vivo evaluation
4.1 Clinical and macroscopic evaluation
The average flow in the carotid artery before occlusion was
248 ± 4 ml/min. One hour after hydrogel implantation,
flow was zero in all three sheep. Perioperative angiography
confirmed this finding. Doppler flow measurements and
angiography (Fig. 3) 4 weeks later showed a persistent
occlusion. At that time some filling defect and decrease in
vessel diameter was visible proximal to the hydrogel.
Evaluation of the pressure directly after implantation
showed a slightly lower pressure distal from the hydrogel
(mean pressure: 65 ± 16 mmHg) compared to the proxi-
mal pressure (mean pressure: 74 ± 21 mmHg). Four
weeks after implantation the difference in mean arterial
pressure in front and behind the hydrogel is still measur-
able, 74 ± 17 and 62 ± 14 mmHg, respectively. Daily
evaluation showed no evidence of any health problems in
any off the sheep. There were no signs of organ failure,
stroke or infection. Blood sample evaluation (Fig. 4) gave
normal values throughout the experiment. Ion concentra-
tions were normal. There were no indications of haemol-
ysis, as lactate dehydrogenase (LDH) and plasma
haemoglobin levels were normal. No indication of kidney
failure either as urea and creatinin were low. There was
also no evidence of cholestatic liver disease; bilirubin
levels were below 0.18 mg/dL. All blood cell counts were
normal, without any sign of inflammation and the number
of white blood cells (WBC) being low. Furthermore,
cerebral evaluation by an experienced radiologist did not
show any sign of cerebral infarction caused by
embolization.
Macroscopic evaluation, at time of explantation, showed
an intact carotid artery. There were no firm adhesions of
the vessel to its surrounding. Mild adhesions were seen a
distance away from the hydrogels at the dissection and
sheath insertion locations. The hydrogels were not attached
to the vessel wall and fell out when the vessel was opened.
There were small thrombi adjacent to both sides of the
hydrogel (Fig. 5). Around the hydrogel there was a
remarkable thrombus in one of the sheep (ID: 1172).
Macroscopic evaluation of the vascular wall showed
impairments in two of the sheep. In sheep 1178 there were
two radial cracks, and in sheep 1172 there was a deep ulcer
at the distal side of the hydrogel. Full autopsy could not
reveal any sign of embolization, infarction, nor bleeding in
the organs.
4.2 Microscopic evaluation
An overview of the microscopic evaluation is depicted in
Table 1. Microscopy of the vessels showed that the
intima was morphologically intact in all randomly taken
samples. There was a mild inflammatory reaction in the
media of samples that were in contact with the hydrogel
(Fig. 6). No fibrotic reaction could be visualized and
tissue fibres were intact. A mild inflammatory reaction
was also visualized in the adventitia in comparison with
the unaffected carotid artery. A specific evaluation of the
ulcer in sheep 1172 showed disruption of the intima and
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contact with a diluted extract of the hydrogel, versus a positive
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an extensive fibrotic and inflammatory reaction in the
media. There was a moderate decrease in media thickness
after contact with the hydrogel with a mean value of
268 lm ± 131, versus 545 lm ± 102 in the control
samples, respectively.
5 Discussion
Hydrogels for medical applications represent a substan-
tially under-investigated field of research. But there is an
increasing interest as new hydrogel functionalities are
Fig. 3 CT images of the occluded carotid artery
0
1
2
3
4
5
6
7
Potassium
m
m
ol
/L
0
20
40
60
80
100
120
140
160
Sodium
m
m
ol
/L
0
20
40
60
80
100
120
Chloride
m
m
ol
/L
0
5
10
15
20
25
30
35
Bicarbonate
m
m
ol
/L
0
5
10
15
20
25
Urea
m
g/
dL
0
0.2
0.4
0.6
0.8
1
1.2
1.4
Creatinine
m
g/
dL
0
100
200
300
400
500
600
700
800
LDH
m
g/
dL
0
2
4
6
8
10
12
14
Haemoglobine
g/
dL
0
2
4
6
8
10
12
RBC count
10
**
12
/L
0
2
4
6
8
10
12
WBC count
10
**
9/
L
0
50
100
150
200
250
300
350
Platelets
10
**
9/
L
0
2
4
6
8
10
12
14
16
Haemoglobine (plasm)
m
g/
dL
Fig. 4 Average blood values, with standard deviation, 0 days (white), 14 days (grey), and 28 days (dark grey) after implantation
J Mater Sci: Mater Med (2015) 26:264 Page 5 of 8 264
123
becoming available that might open up new medical device
opportunities. Some of these hydrogel features (e.g. soft
consistency, biostability) are ideal for the intravascular use
of these hydrogels. Previously already some non-stimuli
responsive hydrogels have been used [11, 12], but the more
novel functionalities of today may broaden the field of
intravascular applications.
Per definition a biomaterial is a polymer whose surface
is in direct contact with the biological system, so the bio-
compatibility of this material should be assessed [19]. The
initial building block that was selected for developing a
suitable electro-responsive hydrogel was F127 (i.e. a
specific type of pluronic), a material known to be ‘‘bio-
compatible’’ and approved by the FDA (Food and Drug
Administration). The pluronic material was bound with
bismethacrylate (PF127-BMA) and polymerized with
methacrylic acid, using the APS/TEMED initiating system,
to obtain the electro-responsive behaviour [13]. A possible
toxic residue is bismethacrylate, as this remains in the gel if
there is incomplete polymerization. Another possible cause
of toxicity could be the redox initiating system [20]. To
decrease the toxicity potential a rinsing procedure (PBS
solution refreshed three times a day for three consecutive
days) was introduced. Evaluation of haemolytic and cyto-
toxic behaviour of the PF127/MANa was carried out
according to international guidelines [14, 16]. The per-
centage of haemolysis was less than 2 % for the direct and
Fig. 5 Photographs of the explanted carotid arteries. Thrombi can be
seen proximal and distal from the place where the hydrogel has been.
In sheep 1178 there were two vertical cracks (yellow arrow), in sheep
1172 there were thrombi at the vessel wall (white arrow) and an ulcer
(blue arrow) (Color figure online)
Table 1 Overview of the
pathology analysis of the carotid
vessel wall
Intima Media Adventitia
Reaction Inflammation (0–3) Fibres (0–3) Thickness (lm) Inflammation (0–3)
Gel contact 0.33 1.67 0.00 307 ± 129 1.67
Normal 0.00 0.00 0.00 593 ± 298 0.00
Fig. 6 a Gel sample showing a cellular reaction in media and adventitia (arrows); b Control sample of a normal carotid artery (I: intima; M:
media; A: adventitia; H&E staining, 9100)
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indirect tests. Therefore PF127/MANa is considered non-
haemolytic. Both direct and extract testing were performed
as both serve a different goal. The direct testing focuses on
the haemolytic features of the hydrogel as a whole,
including the materials surface properties which are
important in the interaction with a biological environment
and artificial materials [21]. The indirect or extract testing
is important to define haemolytic agents, released within
the environment of the gel after implantation. There was no
indication of toxicity of the hydrogel as there was no
reduction of cell viability by more than 30 %, which is
considered as cut-off point for cytotoxic effects. In vitro
experiments did not prove full biocompatibility as more
complex interactions with foreign material dipped in blood
or tissue fluids occur. It leads to adsorption of biomole-
cules, cells and usually proteins on its surface within even a
few seconds of immersion, followed by secondary inter-
actions like a cellular response and thrombus formation
[22]. For this reason in vivo experiments were performed.
By endovascular implantation of the PF127/MANa
material in the carotid artery of sheep, it was shown that an
occlusion could be obtained within 1 h after implantation.
Four weeks after implantation Doppler and angiographic
evaluation proved complete occlusion. There was a mild
pressure drop over the hydrogel implant when occlusion
occurred. The reason that pressure distal from the occlusion
is relatively high is due to a well-developed collateral cere-
bral circulation in sheep. At time of explantation there were
no signs of disintegration or fragmentation of the hydrogel.
Moreover, cerebral imaging and investigation of organs at
time of autopsy could not show any evidence of emboliza-
tion. There was a limited amount of thrombi adjacent to the
hydrogel device. This was probably caused by no-flow
conditions in the carotid artery due to an effective occlusion.
The presence of hydrogel in the blood may cause loss of, or
damage to, red blood cells and may produce increased levels
of free plasma haemoglobin capable of inducing toxic effect
or other effects whichmay stress the kidneys or other organs.
Frequent biochemical analysis after implantation did not
show any haemolytic or other undesired systemic effects
from the hydrogel. Amacroscopic evaluation of themedium-
term effects of the hydrogel on the vascular wall was carried
out. The PF127/MANa gel did not show to adhere to the
vessel wall and caused no macroscopic reactions outside the
vessel. The radial cracks at the inside of the vessel might
have been caused by traction during explantation of the
artery. It is believed that, because of the already extensive
fibrotic reaction, the defect in the intima of sheep 1172 is a
remnant of damage caused by the sheath or guidewire at time
of implantation. Microscopy showed that the hydrogel pro-
voked a mild inflammatory reaction in the media and
adventitia of the artery. An intact morphology of the vessel
wall was found, but with a mild decrease in media thickness.
To conclude, this study showed that this electro-re-
sponsive hydrogel, which can expand and contract by
several times its original volume, can cause an effective
arterial occlusion whereby the hydrogel is relatively inert
to the vessel wall. As predefined geometrical changes can
be obtained by application of a small voltage to the
hydrogel, it is believed that this material may add signifi-
cant benefits over existing occlusion devices. Moreover, its
geometric adaptation capacity might be of use for other
minimal invasive vascular applications. One example is
prevention of endoleakage after endovascular treatment of
abdominal aortic aneurysms [23]. A second potential
application is using the material for intravascular drug
delivery [24, 25].
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